Arrow tip poison of South American Indians. Induces neuromuscular block through interactions with acetylcholine receptor. Identification as active principle from museum specimen: H. King, J. Chem. Soc. 1935, 1381. Isoln from Chondodendron tomentosum R. & P. Menispermaceae: J. D. Dutcher, J. Am. Chem. Soc. 68, 419 (1946). Purification and structure determn: idem, ibid. 74, 2221 (1952). Revised structure: A. J. Everett et al., Chem. Commun. 1970, 1020. Conformational analysis: B. S. Zhorov, N. B. Brovtsyna, J. Membr. Biol. 135, 19 (1993); by NMR: Y. Fraenkel et al., Biochemistry 33, 644 (1994). Binding characterization: N. Shaker et al., J. Pharmacol. Exp. Ther. 220, 172 (1982); M. E. O'Leary et al., Am. J. Physiol. 266, C648 (1994). Clinical pharmacokinetics and dynamics: D. M. Fisher, Anesthesiology 57, 203 (1982). Toxicity data: H. Rosen et al., Proc. Soc. Exp. Biol. Med. 120, 511 (1965). Clinical trial in prevention of muscle fasciculations: S. C. Harvey et al., Anesth. Analg. 87, 719 (1998). Review of clinial use: G. S. Perotti, J. Am. Assoc. Nurse Anesth. 45, 182-186 (1977). Comprehensive description: C. Papastephanou, Anal. Profiles Drug Subs. 7, 477-500 (1978).
Isoln of l-form from Ch. tomentosum: H. King, Nature 158, 515 (1946); idem, J. Chem. Soc. 1947, 936.
Neuromuscular blocking agent.
Neuromuscular Blocking Agent; Nondepolarizing Agents